| View |
DR-XY27498_PI_01.pdf
|
DR-XY27498
|
Metoprolol Tartrate
|
Neobloc
|
100mg
|
Tablet
|
BETA ADRENOCEPTOR BLOCKER
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 April 2023
|
03 October 2028
|
| View |
|
DR-XY27507
|
Polymyxin B Sulfate/ Neomycin Sulfate/ Dexamethasone
|
Vistacom
|
10,000units/ 3.5g/1g per mL%
|
Ophthalmic Suspension
|
Corticosteroids and anti-infectives in combination
|
El Laboratories, Inc
|
Philippines
|
Renewal
|
23 May 2022
|
08 May 2027
|
| View |
|
DR-XY27520
|
Ioversol
|
Optiray 350
|
741 mg/mL
|
Solution For Iv Injection
|
Radiocontrast Media (Non-ionic)
|
Libel- Flarsheim Canada Inc.
|
Canada
|
Automatic Renewal
|
11 April 2022
|
27 May 2027
|
| View |
|
DR-XY27526
|
Pheniramine Maleate + Naphazoline Hydrochloride
|
Vistallerg
|
3 mg/ 250 mcg per mL (0.3% w/v/0.025% w/v)
|
Ophthalmic Solution
|
Antihistamines/Decongestants
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
18 May 2022
|
20 April 2027
|
| View |
|
DR-XY27532
|
Propofol
|
Diprivan®
|
10 mg/ mL
|
Emulsion for IV Infusion
|
General Anaesthesia
|
Corden Pharma Societa' Per Azioni
|
Italy
|
Automatic Renewal
|
18 March 2022
|
30 May 2027
|
| View |
|
DR-XY27536
|
Metformin Hydrochloride
|
Glumet
|
500 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
11 May 2020
|
31 May 2025
|
| View |
|
DR-XY27540
|
Allopurinol
|
Alunlan
|
300 mg
|
Tablet
|
Antigout
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Automatic Renewal
|
07 April 2022
|
04 June 2027
|
| View |
|
DR-XY27567
|
Cefaclor (As Monohydrate)
|
Lorcef
|
250 mg/5 mL
|
Granules For Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 June 2022
|
07 June 2027
|
| View |
|
DR-XY27569
|
Cefaclor (as Monohydrate)
|
None
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Asian Antibiotics, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
07 June 2027
|
| View |
|
DR-XY27580
|
Mefenamic Acid
|
None
|
250 mg
|
Film-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
17 February 2021
|
03 July 2025
|
| View |
|
DR-XY27607
|
Paracetamol
|
Naprex 250
|
250 mg / 5 mL
|
Suspension (Melon Flavor)
|
-
|
Amherst Laboratories Inc.
|
Philippines
|
-
|
17 December 2020
|
05 November 2025
|
| View |
|
DR-XY27612
|
Paracetamol
|
Biogesic (Orange Flavor)
|
250 mg / 5 mL
|
Suspension
|
Analgesic - Antipyretic
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
25 November 2020
|
29 October 2025
|
| View |
|
DR-XY27623
|
Clindamycin (As Hydrochloride)
|
Tidact
|
150 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
YSP Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
26 May 2022
|
21 June 2027
|
| View |
|
DR-XY27632
|
Clarithromycin
|
Klaz
|
125 mg/ 5 mL
|
Granules for Suspension
|
Antibacterial (Macrolide)
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
17 February 2022
|
24 May 2027
|
| View |
|
DR-XY27633
|
Salbutamol (as sulfate)
|
None
|
2 mg
|
Tablet
|
Drugs for obstructive airway diseases(Selective beta-2-adrenoreceptor agonists)
|
Amherst Laboratories Inc.
|
Philippines
|
Renewal
|
09 June 2022
|
25 May 2027
|
| View |
|
DR-XY27641
|
Clindamycin Hydrochloride
|
Zindal
|
300 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
09 June 2022
|
26 June 2027
|
| View |
|
DR-XY27643
|
Mefenamic Acid
|
Vamgesic
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAIDs)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
26 June 2027
|
| View |
|
DR-XY27651
|
Ceftazidime (As Pentahydrate)
|
Zeptrigen
|
1 gram
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporins)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
Automatic Renewal
|
12 October 2022
|
24 October 2027
|
| View |
|
DR-XY27652
|
Ceftazidime (As Pentahydrate)
|
Zeptrigen
|
500 mg
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporins)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
Automatic Renewal
|
12 October 2022
|
24 October 2027
|
| View |
|
DR-XY27668
|
Methylprednisolone Aceponate
|
Advantan
|
1 mg/g
|
Cream
|
Topical Corticosteroid
|
Bayer HealthCare Manufacturing S.r.l.
|
Italy
|
Renewal
|
26 April 2022
|
05 July 2027
|